| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 720,1 k € | -63.8% | 2,0 M € | +33.6% | 1,5 M € | -9.4% | 1,6 M € | -25.9% | 2,2 M € | +7473.2% | -30,1 k € | — | — | — | — | — | — | — | -1,7 k € | -898.0% | -175,0 € | |||||||||
| EBITDA | -944,4 k € | -240.8% | 670,8 k € | +78.4% | 376,0 k € | +355.8% | 82,5 k € | -82.8% | 480,4 k € | +1648.8% | -31,0 k € | -348.0% | -6,9 k € | +5.0% | -7,3 k € | -64.4% | -4,4 k € | -31.4% | -3,4 k € | +48.8% | -6,6 k € | +14.4% | -7,7 k € | -742.3% | -913,2 € | +58.2% | -2,2 k € | -317.4% | -523,0 € | |
| Operating profit | -960,2 k € | -253.2% | 626,6 k € | +88.4% | 332,5 k € | +713.2% | 40,9 k € | -90.8% | 442,6 k € | +1527.1% | -31,0 k € | -348.0% | -6,9 k € | +5.0% | -7,3 k € | -64.4% | -4,4 k € | -31.4% | -3,4 k € | +48.8% | -6,6 k € | +14.4% | -7,7 k € | -742.3% | -913,2 € | +71.6% | -3,2 k € | +11.4% | -3,6 k € | |
| Profit/loss | -201,8 k € | -105.2% | 3,9 M € | +103.3% | 1,9 M € | +115.4% | 879,6 k € | -97.8% | 39,3 M € | +1128.9% | 3,2 M € | +308599.8% | 1,0 k € | +100.1% | -1,8 M € | -4679.7% | -37,1 k € | +93.1% | -539,0 k € | +91.3% | -6,2 M € | -2012.6% | -294,1 k € | +30.0% | -420,2 k € | +43.4% | -742,6 k € | -1081.2% | -62,9 k € | |
| Equity | 23,7 M € | -0.8% | 23,9 M € | -45.7% | 44,0 M € | +4.5% | 42,1 M € | +2.1% | 41,3 M € | +1805.1% | 2,2 M € | +310.1% | -1,0 M € | +0.1% | -1,0 M € | -238.9% | 742,9 k € | -4.8% | 780,0 k € | -40.9% | 1,3 M € | -82.5% | 7,5 M € | -3.8% | 7,8 M € | -5.1% | 8,2 M € | -8.3% | 9,0 M € | |
| Total assets | 30,2 M € | +2.1% | 29,6 M € | -39.0% | 48,4 M € | +0.7% | 48,1 M € | +9.7% | 43,8 M € | +60.0% | 27,4 M € | -0.8% | 27,6 M € | +16.0% | 23,8 M € | +6.1% | 22,4 M € | +43.9% | 15,6 M € | +33.5% | 11,7 M € | -45.6% | 21,5 M € | +2.7% | 20,9 M € | +21.9% | 17,1 M € | +47.7% | 11,6 M € | |
| Cash | 502,3 k € | +605.5% | 71,2 k € | -25.9% | 96,0 k € | -14.3% | 112,1 k € | +74.9% | 64,1 k € | -94.6% | 1,2 M € | +137752.1% | 864,8 € | -97.4% | 33,9 k € | -92.8% | 471,7 k € | +21361.9% | 2,2 k € | +81.4% | 1,2 k € | -99.5% | 248,3 k € | +360.5% | 53,9 k € | -70.0% | 179,7 k € | +1116.3% | 14,8 k € | |
| Debts | 6,5 M € | +14.6% | 5,7 M € | +29.2% | 4,4 M € | -26.3% | 5,9 M € | +132.6% | 2,6 M € | -89.9% | 25,2 M € | -11.9% | 28,6 M € | +15.7% | 24,7 M € | +16.5% | 21,2 M € | +46.7% | 14,5 M € | +42.8% | 10,1 M € | -26.7% | 13,8 M € | +5.8% | 13,1 M € | +47.4% | 8,9 M € | +242.8% | 2,6 M € | |
| Staff | 14,1 | 13,5 | 12,2 | 13,9 | 15,4 | — | — | — | — | — | — | — | — | — | — | |||||||||||||||
Public limited company · Anderlecht · incorporated on 18/06/2010 · 14,1 ETP
Public limited company loss-making in the latest fiscal year. Cash position rising (+605.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDIGROUP is a Public limited company incorporated in 2010. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Anderlecht. It employs on average 14,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette